Targets of perturbagens

Perturbagen ID : CID51323

Perturbagen : (s)-n-valeryl-n-{[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; Act valsartan; Apo-valsartan; Apo-valsartan/hctz; Auro-valsartan; Auro-valsartan hct; Ava-valsartan; Ava-valsartan hct; Byvalson; Diovan; Diovan hct; Diovan-hct; Dom-valsartan; Entresto; Exforge; Exforge hct; Mylan-valsartan; Mylan-valsartan hctz; N-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)-n-valeryl-l-valine; N-pentanoyl-n-{[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl}-l-valine; Novo-valsartan; Novo-valsartan/hctz; Pms-valsartan; Pms-valsartan-hctz; Q-valsartan; Q-valsartan hctz; Ran-valsartan; Riva-valsartan; Sandoz valsartan; Sandoz valsartan hct; Teva-valsartan; Teva-valsartan/hctz; Valsartan; Valsartan and hydrochlorothiazide; Valsartan hct; Valsartan hctz; Valsartan-hctz

Target	Effect	Reference
ADRB1	-1	DrugBank
ADRB2	-1	DrugBank
AGTR1	-1	DrugBank; CLUE; STITCH
CA1	-1	DrugBank
CA12	-1	DrugBank
CA2	-1	DrugBank
CA4	-1	DrugBank
CA9	-1	DrugBank
CACNA1B	-1	DrugBank
CACNA1C	-1	DrugBank
CACNA1D	-1	DrugBank
CACNA1S	-1	DrugBank
CACNA2D1	-1	DrugBank
CACNA2D3	-1	DrugBank
CACNB1	-1	DrugBank
CACNB2	-1	DrugBank
MME	-1	DrugBank
SLC12A3	-1	DrugBank
ALB	2	STITCH
CCL2	2	STITCH
KCNMA1	2	DrugBank
REN	2	STITCH
SMPD1	2	DrugBank